Skip to main content
NCBI home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1975 Jun;31(6):603–613. doi: 10.1038/bjc.1975.106

Protection of mice against cancer by immunization with membranes but not purified virions from virus infected cancer cells.

I P Griffith, N E Crook, D O White
PMCID: PMC2009475  PMID: 1174440

Abstract

The life span of C57/Bl mice inoculated with Lewis lung carcinoma cells was prolonged if the mice were pre-immunized with membranes from these cells infected in vitro with influenza virus. Likewise, BALB/c mice were protected against the malignant tumour WEHI-11 by prior immunization with extracts of cultured WEHI-11 cells which had been infected with influenza virus or Semiliki Forest virus (SFV). Partially purified SFV grown in WEHI-11 cells also protected mice from cancer grafts but neither highly purified SFV nor the glycoprotein from the envelope of this virus protected the mice. It is concluded that SFV-induced immunopotentiation against cancer is not due to covalent linkage of tumour specific transplantation antigen (TSTA) to viral envelope protein but more probably is due to the apposition of viral glycoprotein and cellular TSTA in the plasma membrane of the cancer cell.

Full text

PDF
603

Images in this article

609Fig. 5
on p.609

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bekesi J. G., St-Arneault G., Holland J. F. Increase of leukemia L1210 immunogenicity by Vibrio cholerae neuraminidase treatment. Cancer Res. 1971 Dec;31(12):2130–2132. [PubMed] [Google Scholar]
  2. Beverley P. C., Lowenthal R. M., Tyrrell D. A. Immune responses in mice to tumour challenge after immunization with Newcastle disease virus-infected or x-irradiated tumour cells or cell fractions. Int J Cancer. 1973 Jan 15;11(1):212–223. doi: 10.1002/ijc.2910110125. [DOI] [PubMed] [Google Scholar]
  3. Boone C. W., Blackman K. Augmented immunogenicity of tumor cell homogenates infected with influenza virus. Cancer Res. 1972 May;32(5):1018–1022. [PubMed] [Google Scholar]
  4. Boone C. W., Paranjpe M., Orme T., Gillette R. Virus-augmented tumor transplantation antigens: evidence for a Helper antigen mechanism. Int J Cancer. 1974 Apr 15;13(4):543–551. doi: 10.1002/ijc.2910130414. [DOI] [PubMed] [Google Scholar]
  5. Boone C., Blackman K., Brandchaft P. Tumour immunity induced in mice with cell-free homogenates of influenza virus-infected tumour cells. Nature. 1971 May 28;231(5300):265–266. doi: 10.1038/231265a0. [DOI] [PubMed] [Google Scholar]
  6. Brandchaft P. B., Boone C. W. Increase in Gross (G) antigen sites on the surface of AKR virus-induced rat lymphoma cells after treatment with trypsin. J Immunol. 1974 Jul;113(1):94–102. [PubMed] [Google Scholar]
  7. CLARKE D. H., CASALS J. Techniques for hemagglutination and hemagglutination-inhibition with arthropod-borne viruses. Am J Trop Med Hyg. 1958 Sep;7(5):561–573. doi: 10.4269/ajtmh.1958.7.561. [DOI] [PubMed] [Google Scholar]
  8. Currie G. A., Bagshawe K. D. The role of sialic acid in antigenic expression: further studies of the Landschütz ascites tumour. Br J Cancer. 1968 Dec;22(4):843–853. doi: 10.1038/bjc.1968.99. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. DAWSON C. R., EPSTEIN M. A., HUMMELER K. CYTOCHEMICAL AND ELECTRON MICROSCOPICAL OBSERVATIONS ON THE PRESENCE AND ORIGIN OF ADENOSINE TRIPHOSPHATASE-LIKE ACTIVITY AT THE SURFACE OF TWO MYXOVIRUSES. J Bacteriol. 1965 Jun;89:1526–1532. doi: 10.1128/jb.89.6.1526-1532.1965. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Eaton M. D., Heller J. A., Scala A. R. Enhancement of lymphoma cell immunogenicity by infection with nononcogenic virus. Cancer Res. 1973 Dec;33(12):3293–3298. [PubMed] [Google Scholar]
  11. FAZEKAS DE ST. GROTH S., GRAHAM D. M. The production of incomplete virus particles among influenza strains: chemical induction of the von Magnus phenomenon. Br J Exp Pathol. 1955 Apr;36(2):205–213. [PMC free article] [PubMed] [Google Scholar]
  12. Holland J. J., Kiehn E. D. Influenza virus effects on cell membrane proteins. Science. 1970 Jan 9;167(3915):202–205. doi: 10.1126/science.167.3915.202. [DOI] [PubMed] [Google Scholar]
  13. Häkkinen I., Halonen P. Induction of tumor immunity in mice with antigens prepared from influenza and vesicular stomatitis virus grown in suspension culture of Ehrlich ascites cells. J Natl Cancer Inst. 1971 Jun;46(6):1161–1167. [PubMed] [Google Scholar]
  14. Klein P. A. Adaptation of influenza virus to growth in cultured murine methylcholanthrene induced tumors. Arch Gesamte Virusforsch. 1974;45(3):199–208. doi: 10.1007/BF01249682. [DOI] [PubMed] [Google Scholar]
  15. Kobayashi H., Sendo F., Kaji H., Shirai T., Saito H., Takeichi N., Hosokawa M., Kodama T. Inhibition of transplanted rat tumors by immunization with identical tumor cells infected with Friend virus. J Natl Cancer Inst. 1970 Jan;44(1):11–19. [PubMed] [Google Scholar]
  16. Laemmli U. K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970 Aug 15;227(5259):680–685. doi: 10.1038/227680a0. [DOI] [PubMed] [Google Scholar]
  17. Lindenmann J. Immunogenicity of oncolysates obtained from Ehrlich ascites tumors infected with vesicular stomatitis virus. Arch Gesamte Virusforsch. 1970;31(1):61–70. doi: 10.1007/BF01241666. [DOI] [PubMed] [Google Scholar]
  18. Lindenmann J., Klein P. A. Viral oncolysis: increased immunogenicity of host cell antigen associated with influenza virus. J Exp Med. 1967 Jul 1;126(1):93–108. doi: 10.1084/jem.126.1.93. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Lindenmann J. Viruses as immunological adjuvants in cancer. Biochim Biophys Acta. 1974 Apr 29;355(1):49–75. doi: 10.1016/0304-419x(74)90007-9. [DOI] [PubMed] [Google Scholar]
  20. Simons K., Keränen S., Käriänen L. Identification of a precursor for one of the Semliki forest virus membrane proteins. FEBS Lett. 1973 Jan 15;29(2):87–91. doi: 10.1016/0014-5793(73)80532-0. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES